Iradimed (IRMD) Asset Writedowns and Impairment (2014 - 2026)
Iradimed's (IRMD) quarterly Asset Writedowns and Impairment came in at $15000.0 in Q1 2026, up 200.0% year-on-year from $5000.0 in Q1 2025, and down 88.47% on a QoQ basis from $130125.0 in Q4 2025.
Iradimed (IRMD) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends
Iradimed (IRMD) has 13 years of Asset Writedowns and Impairment data on file, last reported at $15000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 200.0% year-over-year to $15000.0 in Q1 2026; TTM through Mar 2026 was $77000.0, a 126.48% increase from a year earlier, with the FY2025 full-year figure at $47000.0, down 46.59% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $15000.0, down from $130125.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for IRMD reached as high as $180788.0 in Q1 2023 and fell as low as -$109925.0 in Q3 2024.
- Historically, Asset Writedowns and Impairment has averaged $22775.3 across 5 years, with a median of $9403.0 in 2022.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 1375.34% in 2023 and fell as far as 462.38% in 2023.
- Year by year, Asset Writedowns and Impairment stood at $26510.0 in 2022, then surged by 68.29% to $44613.0 in 2023, then surged by 302.12% to $179398.0 in 2024, then retreated by 27.47% to $130125.0 in 2025, then tumbled by 88.47% to $15000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $15000.0 in Q1 2026, $130125.0 in Q4 2025, and -$50236.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Iradimed | 1.21 Bn | 1.15 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 130,125.00 |
| Dec 31, 2025 | 130,125.00 |
| Sep 30, 2025 | -50,236.00 |
| Sep 30, 2025 | -50,236.00 |
| Jun 30, 2025 | -17,889.00 |
| Jun 30, 2025 | -17,889.00 |
| Mar 31, 2025 | -15,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 179,398.00 |
| Dec 31, 2024 | 179,398.00 |
| Sep 30, 2024 | -109,925.00 |
| Sep 30, 2024 | -109,925.00 |
| Jun 30, 2024 | -20,474.00 |
| Jun 30, 2024 | -20,474.00 |
| Mar 31, 2024 | 39,001.00 |
| Mar 31, 2024 | 39,001.00 |
| Dec 31, 2023 | 44,613.00 |
| Dec 31, 2023 | 44,613.00 |